(Q37878139)

English

No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study

scientific article published on July 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 August 2017

No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study (English)

1 reference

Europe PubMed Central

24 August 2017

0 references

multicenter clinical trial

0 references

reactive arthritis

1 reference

based on heuristic

inferred from title

1 reference

ORCID Public Data File 2021

author name string

Sieper J

1

1 reference

Europe PubMed Central

24 August 2017

Fendler C

2

1 reference

Europe PubMed Central

24 August 2017

Laitko S

3

1 reference

Europe PubMed Central

24 August 2017

Sörensen H

4

1 reference

Europe PubMed Central

24 August 2017

Gripenberg-Lerche C

5

1 reference

Europe PubMed Central

24 August 2017

Hiepe F

6

1 reference

Europe PubMed Central

24 August 2017

Alten R

7

1 reference

Europe PubMed Central

24 August 2017

Keitel W

8

1 reference

Europe PubMed Central

24 August 2017

Groh A

9

1 reference

Europe PubMed Central

24 August 2017

Uksila J

10

1 reference

Europe PubMed Central

24 August 2017

Eggens U

11

1 reference

Europe PubMed Central

24 August 2017

Granfors K

12

1 reference

Europe PubMed Central

24 August 2017

Braun J

13

1 reference

Europe PubMed Central

24 August 2017

publication date

1 July 1999

1 reference

Europe PubMed Central

24 August 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

24 August 2017

42

1 reference

Europe PubMed Central

24 August 2017

1386-1396

1 reference

Europe PubMed Central

24 August 2017

7

1 reference

Europe PubMed Central

24 August 2017

Reiter's Syndrome and Reactive Arthritis in Perspective

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

A wider spectrum of spondyloarthropathies

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

The value of specific antibody detection and culture in the diagnosis of reactive arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Comparison of synovial tissue and synovial fluid as the source of nucleic acids for detection of Chlamydia trachomatis by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Chlamydia trachomatis and reactive arthritis: the missing link

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Yersinia antigens in synovial-fluid cells from patients with reactive arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Diagnosis and treatment of Lyme arthritis.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Human serology in Chlamydia trachomatis infection with microimmunofluorescence

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Yersinia-specific antibodies in serum and synovial fluid in patients with Yersinia triggered reactive arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Serological diagnosis of salmonella infections by enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Salmonella-triggered reactive arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Antibodies against an acid extract from a single Campylobacter strain in hospitalized campylobacter patients

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

The value of isotype determination of serum antibodies against Chlamydia for the diagnosis of Chlamydia reactive arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Salmonella-triggered reactive arthritis: use of polymerase chain reaction, immunocytochemical staining, and gas chromatography-mass spectrometry in the detection of bacterial components from synovial fluid.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

The detection of DNA from a range of bacterial species in the joints of patients with a variety of arthritides using a nested, broad-range polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Yersinia-triggered reactive arthritis. Use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Antibiotic prophylaxis and treatment of reactive arthritis. Lessons from an animal model

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Reactive arthritis following an outbreak of Salmonella Bovismorbificans infection.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Antibiotic Treatment of Venereal Disease and Reiter's Syndrome in a Greenland Population

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both?

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Ciprofloxacin-induced neutropenia and erythema multiforme

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Chlamydia trachomatis Can Persist in Joint Tissue After Antibiotic Treatment in Chronic Reiter's Syndrome / Reactive Arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199907%2942%3A7%3C1386%3A%3AAID-ANR12%3E3.0.CO%3B2-E

21 January 2018

Identifiers

10.1002/1529-0131(199907)42:7<1386::AID-ANR12>3.0.CO;2-E

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37878139&oldid=2034616874"